P Bolton-Maggs

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. pmc Epirubicin for breast cancer may cause considerable venous sclerosis
    Paula Bolton-Maggs
    Department of Clinical Haematology, Manchester Royal Infirmary, Manchester M13 9WL
    BMJ 331:816. 2005
  2. ncbi request reprint A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
    Paula H B Bolton-Maggs
    Department of Haematology, Manchester Royal Infirmary, Manchester, UK
    Br J Haematol 135:603-33. 2006
  3. doi request reprint Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
    Paula H B Bolton-Maggs
    SHOT Office, Manchester Blood Centre and University of Manchester, Manchester, UK
    Br J Haematol 163:303-14. 2013
  4. doi request reprint Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme
    P H B Bolton-Maggs
    University of Manchester, and Serious Hazards of Transfusion Office, Manchester Blood Centre, Manchester, UK
    BJOG 120:873-8. 2013
  5. ncbi request reprint Commentary on session: Immune thrombocytopenia nomenclature, guidelines, and natural history
    Paula H B Bolton-Maggs
    Serious Hazards of Transfusion Programme, University of Manchester, Manchester Blood Centre, Manchester, UK
    Semin Hematol 50:S10-1. 2013
  6. doi request reprint The rare inherited coagulation disorders
    Paula H B Bolton-Maggs
    University of Manchester, Manchester Blood Centre, Plymouth Grove, Manchester, UK
    Pediatr Blood Cancer 60:S37-40. 2013
  7. doi request reprint Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders
    P H B Bolton-Maggs
    University of Manchester and Manchester Blood Centre, Manchester, UK
    Haemophilia 18:66-72. 2012
  8. doi request reprint Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update
    Paula H B Bolton-Maggs
    University of Manchester, Manchester, UK
    Br J Haematol 156:37-49. 2012
  9. ncbi request reprint Acute immune thrombocytopenic purpura. To treat or not to treat?
    P Bolton-Maggs
    Department of Clinical Haematology, Central Manchester and Manchester Children s University Hospitals, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, England
    Hamostaseologie 29:74-5. 2009
  10. doi request reprint von Willebrand disease update: diagnostic and treatment dilemmas
    P H B Bolton-Maggs
    Manchester Royal Infirmary, Oxford Road, Manchester, UK
    Haemophilia 14:56-61. 2008

Detail Information

Publications17

  1. pmc Epirubicin for breast cancer may cause considerable venous sclerosis
    Paula Bolton-Maggs
    Department of Clinical Haematology, Manchester Royal Infirmary, Manchester M13 9WL
    BMJ 331:816. 2005
  2. ncbi request reprint A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
    Paula H B Bolton-Maggs
    Department of Haematology, Manchester Royal Infirmary, Manchester, UK
    Br J Haematol 135:603-33. 2006
    ....
  3. doi request reprint Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
    Paula H B Bolton-Maggs
    SHOT Office, Manchester Blood Centre and University of Manchester, Manchester, UK
    Br J Haematol 163:303-14. 2013
    ..The recommendations on reduction of errors through a 'back to basics' approach from the first annual SHOT report remain absolutely relevant today...
  4. doi request reprint Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme
    P H B Bolton-Maggs
    University of Manchester, and Serious Hazards of Transfusion Office, Manchester Blood Centre, Manchester, UK
    BJOG 120:873-8. 2013
    ..To highlight the errors associated with the use of anti-D immunoglobulin in RhD antigen-negative women, and their resultant clinical impact during and after pregnancy, and to suggest strategies to reduce these errors...
  5. ncbi request reprint Commentary on session: Immune thrombocytopenia nomenclature, guidelines, and natural history
    Paula H B Bolton-Maggs
    Serious Hazards of Transfusion Programme, University of Manchester, Manchester Blood Centre, Manchester, UK
    Semin Hematol 50:S10-1. 2013
    ..Participants noted the two new guidelines gave discrepant advice with regard to splenectomy. Management of ITP is not necessarily straightforward and needs to be tailored to the individual...
  6. doi request reprint The rare inherited coagulation disorders
    Paula H B Bolton-Maggs
    University of Manchester, Manchester Blood Centre, Plymouth Grove, Manchester, UK
    Pediatr Blood Cancer 60:S37-40. 2013
    ..Factor VII and factor XI deficiencies show a poor relationship between the factor level and bleeding risk. Unlike hemophilia, women are equally affected by these RICD and can have problems related to menstruation and childbirth...
  7. doi request reprint Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders
    P H B Bolton-Maggs
    University of Manchester and Manchester Blood Centre, Manchester, UK
    Haemophilia 18:66-72. 2012
    ..Factor XIII deficiency is a rare, but important bleeding disorder, which may be missed or diagnosed late. A discussion and update on this diagnosis is considered in the final section of our review...
  8. doi request reprint Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update
    Paula H B Bolton-Maggs
    University of Manchester, Manchester, UK
    Br J Haematol 156:37-49. 2012
    ..The diagnostic value of the eosin-5-maleimide (EMA) binding test has been validated in a number of studies with understanding of its limitations...
  9. ncbi request reprint Acute immune thrombocytopenic purpura. To treat or not to treat?
    P Bolton-Maggs
    Department of Clinical Haematology, Central Manchester and Manchester Children s University Hospitals, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, England
    Hamostaseologie 29:74-5. 2009
    ..It is notable that adults with ITP may die from infection, probably related to therapy...
  10. doi request reprint von Willebrand disease update: diagnostic and treatment dilemmas
    P H B Bolton-Maggs
    Manchester Royal Infirmary, Oxford Road, Manchester, UK
    Haemophilia 14:56-61. 2008
    ..Type 3 VWD is the most severe form of VWD and a new international study is underway to examine the use of prophylaxis...
  11. pmc Transition of care from paediatric to adult services in haematology
    Paula H B Bolton-Maggs
    Department of Clinical Haematology, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK
    Arch Dis Child 92:797-801. 2007
    ..Despite these initiatives only slow progress has been made (usually by enthusiasts) and much work is needed to develop good programmes in many specialties, including non-malignant haematology...
  12. ncbi request reprint Optimal haemophilia care versus the reality
    Paula H B Bolton-Maggs
    Manchester Haemophilia Comprehensive Care Centre, Manchester Royal Infirmary, Manchester, UK
    Br J Haematol 132:671-82. 2006
    ..The development of inhibitory antibodies seriously complicates the management both in morbidity and cost. While gene therapy has not yet produced the hoped-for cure, new technologies will produce improved products...
  13. ncbi request reprint A framework for genetic service provision for haemophilia and other inherited bleeding disorders
    C A Ludlam
    Department of Haematology, Royal Infirmary, Edinburgh, UK
    Haemophilia 11:145-63. 2005
    ....
  14. ncbi request reprint Haemophilias A and B
    Paula H B Bolton-Maggs
    Department of Haematology, Royal Liverpool Children s Hospital, Liverpool, UK
    Lancet 361:1801-9. 2003
    ..The future holds the realistic possibility of gene therapy. However, we must not forget that haemophilia is a worldwide disorder that requires significant economic resources not available for the majority...
  15. ncbi request reprint Haemophilia--paucity of evidence, ways forward?
    Paula H B Bolton-Maggs
    Manchester Haemophilia Comprehensive Care Centre, Department of Clinical Haematology, Manchester Royal Infirmary, Manchester, UK
    Blood Coagul Fibrinolysis 14:S7-9. 2003
    ..Some preliminary questions can establish areas where new clinical studies are needed...